Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C

Equality Impact Assessment (Guidance development) (PDF 228 KB)

Final appraisal determination

Final appraisal determination document (PDF 358 KB)

Committee papers (PDF 7.42 MB)

Public committee slides (PDF 614 KB)

Final scope (PDF 275 KB)

NICE's response to comments on the draft scope and provisional matrix (PDF 313 KB)

Final matrix (PDF 267 KB)

Draft scope pre referral (PDF 287 KB)

Draft matrix pre referral (PDF 265 KB)